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CABG: coronary artery bypass graft 18 
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CT: computerised tomography 20 
MDT: multidisciplinary team 21 
MV: mitral valve 22 
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PPE Personal Protective Equipment 24 
STEMI: ST-elevation myocardial infarction 25 
TAVI: Transcatheter aortic valve implantation  26 
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Central picture: Distribution of 86 consultants who responded to the survey across macro-27 
areas in the United Kingdom (UK)   28 
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Central message: 29 
No firm recommendations are currently available to guide decision making for patients 30 
requiring cardiac surgery during the pandemic. This can translate into significant variation in 31 
clinical practice and patient outcomes. A systematic appraisal of senior surgeons’ consensus 32 
can represent a rapid and efficient instrument to inform health policy makers and 33 
stakeholders to make interim recommendations until data from clinical observations will 34 
become available. 35 
Perspective statement: 36 
Systematic appraisal of senior surgeons’ consensus can be used to generate interim 37 
recommendations for patients undergoing cardiac surgery during COVID-19 pandemic 38 




Background: No firm recommendations are currently available to guide decision making for 41 
patients requiring cardiac surgery during the COVID-19 pandemic. Systematic appraisal of 42 
senior surgeons’ consensus can be used to generate interim recommendations until data 43 
from clinical observations will become available. Hence, we aimed to collect and 44 
quantitatively appraise nationwide UK consultants’ opinion on clinical decision making for 45 
patients requiring cardiac surgery during the COVID-19 pandemic.  46 
Methods: We mailed a web-based questionnaire to all consultant cardiac surgeons through 47 
the Society for Cardiothoracic Surgery in Great Britain and Ireland (SCTS) mailing list on the 48 
17th April 2020 and we pre-determined to close the survey on the 21st April 2020. This survey 49 
was primarily designed to gather information on UK surgeons’ opinion using 12 items. Strong 50 
consensus was predefined as an opinion shared by at least 60% of responding consultants. 51 
Results: A total of 86 consultant surgeons undertook the survey. All UK cardiac units were 52 
represented by at least one consultant. Strong consensus was achieved for the following key 53 
questions:1) before any hospital admission for cardiac surgery, nasopharyngeal swab, r-PCR 54 
and chest CT should be performed; 2) the use of full PPE should to be adopted in every case 55 
by the theatre team regardless patient’s COVID-19 status; 3) the risk of COVID-19 exposure 56 
for patients undergoing heart surgery should be considered moderate to high and likely to 57 
increase mortality if it occurs; 4) cardiac procedure should be decided based on a rapidly 58 
convened multidisciplinary team discussion for every patient. The majority believed that both 59 
aortic and mitral surgery should be considered in selected cases. The role of coronary 60 
artery bypass graft surgery during the pandemic was controversial. 61 
Conclusions: In this unprecedented pandemic period, this survey provides information for 62 





The Coronavirus disease 2019 (COVID-19) pandemic has had an unprecedented impact on 66 
healthcare globally, including on the delivery of cardiac surgical care [1-2]. Cardiac surgery is 67 
the single largest user of intensive care unit beds [1-2]. The re-allocation of ITU capacity to 68 
treat COVID-19 patients has adversely affected the provision of routine cardiac surgery in the 69 
United Kingdom and worldwide. Urgent and emergency cardiac surgical procedures are still 70 
required by the public during the pandemic. There remain several areas of uncertainty., These 71 
include the risks incurred by patients with pre-existing cardiac conditions, who may suffer fatal 72 
events if surgery is delayed by several weeks, the impact of acquiring COVID-19 during the 73 
pandemic and the and the anecdotal evidence that post-operative COVID-19 infection may be 74 
fatal.  75 
No firm recommendations are currently available to guide decision making for patients 76 
requiring cardiac surgery during the pandemic. This can translate into significant variability in 77 
clinical practice and patients’ outcomes across cardiac units. In these circumstances, consensus 78 
among senior surgeons nationally or globally can provide interim guidance for healthcare 79 
policy makers, for clinicians’ daily practice and for patients [3]. We aimed to collect and 80 
quantitatively appraise nationwide UK senior surgeons’ opinion on clinical decision making 81 
for patients requiring cardiac surgery during the COVID-19 pandemic.  82 
Participants and methods 83 
We mailed a web-based questionnaire to a total of 198 consultant cardiac surgeons from 35 84 
UK cardiac centres through the Society for Cardiothoracic Surgery in Great Britain and Ireland 85 
(SCTS) mailing list on the 17th April 2020. Our aim was to receive at least 1 response from 86 
each unit to inform a national picture of practice. In view of the rapidly evolving circumstances 87 
and the need for timely outcome presentation, we pre-determined to close the survey on the 88 
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21st April 2020. This survey was primarily designed to gather information on UK surgeons’ 89 
opinion on which patients should be considered for cardiac surgery under the current COVID-90 
19 pandemic using 12 items. As at the time of the survey, there was significant variability on 91 
clinical activities across centres, the first part of the questionnaire gathered information on local 92 
factors (local resource relocation to treat COVID-19) that may have influenced surgeons’ view. 93 
Strong consensus was predefined as an opinion shared by at least 60% of responding 94 
consultants [3].  95 
Results  96 
A total of 86 consultant surgeons undertook the survey. There was at least one senior surgeon 97 
who took part to the survey from each of the 35 cardiac units. Figure 1 shows the distribution 98 
of responding consultants across different regions and the proportion of consultant stratified by 99 
local resource relocation. Geographical regions with the highest number of responding 100 
consultants were London, North West and Northern regions. Most consultants were from units 101 
where resources were only partially redirected to treat COVID-19 (n=63, 73%) followed by 102 
consultants working in units entirely relocated (n=17, 18%) and only nine consultants were 103 
from in units where resources were not redirected (10%).  Table 1 shows the results of the 104 
survey in the overall sample and in groups stratified by working in units with resource 105 
relocation.  106 
In the overall sample, strong consensus (≥60%) was achieved for the following key 107 
questions:1) before hospital admission every patient should receive nasopharyngeal swab, 108 
polymerase chain reaction (PCR) and chest computerised tomography (CT); 2) the use of full 109 
Personal Protective Equipment (PPE) should to be adopted in every case by the theatre team 110 
regardless of the patient’s COVID-19 status; 3) the risk of COVID-19 exposure for patients 111 
undergoing heart surgery should be considered moderate to high and likely to increase 112 
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mortality if it occurs; 4) cardiac procedure should be decided based on ad-hoc multidisciplinary 113 
team (MDT) for every patient. Although there was no strong consensus on other key questions, 114 
the majority (>50%) agreed on that: 1) patients tested COVID-19 positive before salvage 115 
surgery (i.e. dissection), should be considered for surgery only if they have no symptoms of 116 
infection and have best chances of survival (i.e. age, malperfusion); 2) aortic and mitral valve 117 
surgery could similarly be  considered only in selected cases. Interestingly, opinion about who 118 
should have coronary artery bypass graft (CABG) surgery was much more varied. Although 119 
the most common answer  was that CABG surgery should be considered only in selected cases 120 
(i.e. age criteria or left main disease) (41%), about a third of the responding surgeons  believed 121 
that percutaneous coronary intervention (PCI) should always be the default strategy (33%). 122 
Overall, a small number of surgeons believed that urgent or elective surgery should never be 123 
performed (2% and 9% respectively). When the outcomes of the survey were stratified by 124 
resource relocation, surgeons from units where resources were not relocated (i.e. units which 125 
are carrying on as normal) showed a very strong agreement (>85%) that the risk of COVID-19 126 
exposure for patients undergoing cardiac surgery is moderate to high and likely to increase 127 
mortality if it occurs. This group also showed the highest proportion of surgeons believing that 128 
cardiac surgery should never be performed in urgent (25%) or elective patients (38%). Finally, 129 
there was a strong consensus that this pandemic will not have an impact on surgical activities 130 
when normal operating conditions will be re-established.  131 
Comments 132 
We are realising that non COVID-19 infection related deaths may be an extremely 133 
important unintended consequence of the COVID-19 pandemic due to the re allocation of 134 
health resources. However, there is little direct evidence to inform the management of patients 135 
requiring cardiac surgery under the current rapidly evolving circumstances. Initial reports 136 
have suggested that non COVID-19 related cardiovascular mortality and morbidity are 137 
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likely to be significantly affected [4]. In particular, the number of cardiac surgeries has 138 
dramatically decreased as intensive care facilities and staff have been urgently redeployed 139 
to treat COVID-19 patients. Even though cardiac surgeons are still required to ensure that 140 
essential cardiac interventions are provided to the public, the risk of COVID exposure 141 
during hospital admission and its potential impact on surgical outcomes during hospital 142 
admission remains uncertain. In healthcare systems where surgeons’ mortality is under 143 
public and regulatory bodies scrutiny, such as in the UK, surgeons may be reluctant to 144 
offer cardiac operations under the current circumstances. To avoid the risk of inappropriate 145 
risk adverse practice, UK regulatory bodies including the SCTS have decided to suspend 146 
surgeons’ specific mortality, but national and unit outcomes remain under strict 147 
surveillance.  148 
Anecdotal evidence that patients are reluctant to go to a hospital during the COVID-19 149 
outbreak [4]. Patient’s counselling is particularly challenging as risk stratification methods 150 
available do not account for COVID-19 exposure and it takes more time and empathy than 151 
ever to help a patient give consent for their cardiac surgery.  152 
In the UK, there are rich resources of routinely clinical data, including the National Adults 153 
Cardiac Surgical Audit (NACSA) which will provide essential information on the impact of 154 
the COVID-19 pandemic on patients undergoing cardiac surgery. However, clinical 155 
observations are accumulating slowly due to drastic reduction of cardiac surgeries performed 156 
and data-driven evidence results may not be available until late spring or early fall. As a result, 157 
no firm recommendations are available for case selection and clinical decision making in 158 
patients referred to cardiac surgery. In clinical scenarios without compelling evidence, 159 
expert consensus can provide information for interim clinical recommendations. The 160 
present survey collected opinions from senior cardiac surgeons in the UK and results are 161 
consistent with recent recommendations made by the Society of Thoracic Surgery [5].  162 
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First, surgeons agreed that before hospital admission for cardiac surgery, screening needs 163 
to include nasopharyngeal swab, PCR, and chest CT for every patient during the pandemic. 164 
Screening is essential to contain the infections and avoid post-operative complications. The 165 
definite diagnosis of COVID-19 is based on the viral isolation or positive result of PCR 166 
from sputum, or nasal swab, or throat swab. However, a high false-negative rate of PCR 167 
results for COVID-19 detection has been reported [6]. The combination of multiple 168 
diagnostic tests (i.e. PCR and chest CT) reduces the risk of false negative.  Although it is 169 
difficult to distinguish COVID-19 pneumonia from other viral pneumonia on CT findings 170 
alone, the utility of chest CT to detect early change of COVID-19 in cases which PCR tests 171 
show negative results has been largely emphasized [6]. Positive screening tests should lead 172 
to reconsideration of the risks and benefits of proceeding with surgery. These patients may 173 
be in the pre phase of infection and are likely at higher risk of adverse outcomes following 174 
surgery. Most surgeons and particularly those working in units currently unaffected by the 175 
pandemic, believed that the risk of COVID exposure for patients admitted for a cardiac 176 
operation is moderate to high and can have serious consequences on patient’s outcome. 177 
This is likely related to the fact that after cardiac surgery patients can be particularly 178 
vulnerable to pulmonary complications caused by COVID-19. Intense screening in 179 
patients referred to cardiac surgery is desirable to improve patient’s outcomes. However, 180 
if the pandemic continues for months as anticipated by some researchers [7], possible 181 
consequences of intense screening will need to be evaluated. For instance, it is unclear 182 
whether delay in treatment due to screening can result in adverse events in unstable patients 183 
and whether chest CT can be avoided in selected cases to mitigate the risk of radiation. 184 
Surgeons also agreed that the theatre team should adopt full PPE for all the procedures 185 
performed during the pandemic. While preoperative screening is desirable to minimize the 186 
risk of COVID transmission to the health care providers, the risk of false negative must always 187 
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be considered. Cardiac surgery requires uniquely skilled individuals (cardiac operating 188 
room scrub and circulators, perfusionists, cardiac anaesthesiologists, and perioperative 189 
caregivers) and the risk of exposure to COVID-19, can threaten their availability of for 190 
future more urgent procedures. However, it remains unclear whether the use of full PPE 191 
can negatively affect team performance (i.e. communication, surgical vision and dexterity 192 
and fatigue) and ultimately result in worse clinical outcomes.  193 
There was strong consensus that each surgical case requires ad-hoc multidisciplinary team 194 
decision and patient’s selection at surgeon’s discretion under the current circumstances 195 
was believed to be acceptable only by a very small number of responders. Clearly, 196 
multidisciplinary team discussion for each patient requires flexible approaches such as 197 
conference call discussions or emails exchanges, and consideration must be given to 198 
sensitive data protection and confidentiality and the need of maintaining clinical 199 
documentation standards.  200 
There was no strong consensus with regards to specific types of cardiac procedures. 201 
However, the majority believed that both aortic and mitral surgery should be considered 202 
in selected cases. The role of CABG surgery during the pandemic was more controversial. 203 
Neither consensus nor majority was achieved for CABG surgery in selected cases (i.e. left 204 
main). Despite recent controversies reported by public media [8], a third of responders 205 
suggested that under the current circumstances PCI should always be the default strategy 206 
and CABG surgery should be considered only in unstable patients when PCI is not feasible. 207 
After cardiac surgery, patients are particularly vulnerable to respiratory complications and 208 
the occurrence of COVID-19 associated pneumonia after CABG surgery is likely to be 209 
associated significant morbidity and mortality. During the pandemic, PCI can represent a 210 
temporary solution for patients with complex coronary artery disease. However, no 211 
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definitive evidence exists on the superiority of PCI over CABG in case of COVID-19 212 
exposure.  213 
Finally, despite surgeons’ view on the role of cardiac surgery during the pandemic more 214 
controversial, there was a strong agreement that cardiac surgery activities will be entirely 215 
re-established at the end of the pandemic. Compelling evidence has recently proven that 216 
cardiac surgery remains the best treatment for many patients with cardiac disease despite 217 
new technologies and improvement in transcatheter and percutaneous interventions [9,10].  218 
In conclusion, during the COVID-19 pandemic, healthcare policy makers and hospitals 219 
not only need to consider methods for containing and treating these infections but how 220 
infection outbreaks may affect systems of care beyond the immediate infection. Clinical 221 
decision making for patients requiring cardiac surgery is particularly challenging under 222 
the COVID-19 pandemic as data-driven evidence is still scarce. Worldwide and in the UK, 223 
the lack of firm recommendations for the management of patients requiring cardiac surgery 224 
can translate into unwarranted variation in clinical practice and patients’ clinical outcomes 225 
across units. In the current unprecedented scenario, systematic appraisal of consensus from 226 
senior surgeons at national or international level, can represent a rapid and efficient 227 
instrument to provide support to heath policy makers and other stakeholders in generating 228 
interim recommendations to guide and support clinicians in decision making process.  229 
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Figure 1. Distribution of 86 consultants who responded to the survey across macro-areas in the 
United Kingdom (UK) (left). Proportion of responders stratified based on whether they worked 




Table 1. Results of the survey among 86 consultant cardiac surgeons (at least one from each UK unit) in the overall sample and stratified by 
resource relocation to treat COVID-19. (strong consensus highlighted in yellow, majority in bold; COVID-19: Coronavirus disease 2019; PRC: 
polymerase chain reaction; CT computerised tomography; PPE Personal Protective Equipment; MDT: multidisciplinary team; STEMI: ST-
elevation myocardial infarction; CABG: coronary artery bypass graft; AV: aortic valve; MV: mitral valve; TAVI: Transcatheter aortic valve 
implantation) 
Screening for COVID-19 before patient’s admission for non-salvage cardiac surgery should consist of: Total 
Resource 
relocated    
    No Partially Entirely 
I do not know 1.2% 0.0% 1.6% 0.0% 
nasopharyngeal swab and PCR for suspected cases only 1.2% 12.5% 0.0% 0.0% 
nasopharyngeal swab, PCR and chest CT for every patient 60.5% 62.5% 65.1% 40.0% 
nasopharyngeal swab, PCR and chest CT for suspected case only 5.8% 0.0% 6.3% 6.7% 
nasopharyngeal swab, PCR for every patient. 31.4% 25.0% 27.0% 53.3% 
          
During this pandemic, full PPE should be adopted by the theatre team:          
I don’t know 1.2% 0.0% 1.6% 0.0% 
In every case regardless patient COVID-19 status 60.5% 62.5% 54.0% 86.7% 
Only in a confirmed COVID-19 case or in all cases where COVID-19 screening was not performed 17.4% 12.5% 22.2% 0.0% 
Only in a confirmed or suspect COVID-19 case 20.9% 25.0% 22.2% 13.3% 
     
During this pandemic, the risk of COVID-19 exposure for patients undergoing cardiac surgery is:         
I don’t know 3.5% 0.0% 3.2% 6.7% 
Low but likely to increase mortality if it occurs 25.6% 12.5% 28.6% 20.0% 
Moderate to high and likely to increase mortality if it occurs 69.8% 87.5% 66.7% 73.3% 
Moderate to high but unlikely to increase mortality if it occurs 1.2% 0.0% 1.6% 0.0% 
     
During this pandemic, cardiac surgery operations should be performed:         
As usual following standard recommendations 9.3% 0.0% 11.1% 6.7% 
At surgeons’ discretions 12.8% 12.5% 12.7% 13.3% 
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I don’t know 1.2% 0.0% 1.6% 0.0% 
Only after ad-hoc MDT for every case 64.0% 50.0% 65.1% 66.7% 
Surgery should never be performed unless strictly necessary (i.e. dissection) 12.8% 37.5% 9.5% 13.3% 
     
a patient confirmed or suspected COVID-19 positive presenting with acute type A dissection should be operated on:         
I don’t know 2.3% 12.5% 0.0% 6.7% 
Only if he/she has no symptoms of infection (i.e. no fever, normal blood cell count, normal chest CT) 22.1% 12.5% 23.8% 20.0% 
Only if he/she has no symptoms of infection and has best chances of survival (i.e. age) 53.5% 50.0% 60.3% 26.7% 
Should be considered for surgery only if he/she is unstable (i.e. cardiac tamponade) 17.4% 12.5% 15.9% 26.7% 
Surgery should never be attempted 4.7% 12.5% 0.0% 20.0% 
     
During this pandemic elective surgery for non-COVID patients should be performed:          
All elective cases with priority (i.e. symptoms) to be considered for TAVI or PCI and surgery to be performed only if strictly 
necessary 40.7% 0.0% 42.9% 53.3% 
As usual following standard recommendations 2.3% 0.0% 3.2% 0.0% 
Only in cases with priority (i.e. symptoms) 47.7% 62.5% 46.0% 46.7% 
Surgery should never be performed 9.3% 37.5% 7.9% 0.0% 
     
During this pandemic, surgery for non-COVID inpatients should be performed:          
All inpatients to considered for TAVI or PCI and surgery to be performed only if strictly necessary 40.7% 12.5% 39.7% 60.0% 
As usual following standard recommendations 11.6% 12.5% 14.3% 0.0% 
Only in selected cases (age criteria, anatomy) 45.3% 50.0% 46.0% 40.0% 
Surgery should never be performed 2.3% 25.0% 0.0% 0.0% 
     
During this pandemic, CABG surgery for non-COVID patients should be performed:          
As usual following standard recommendations 4.7% 12.5% 4.8% 0.0% 
Neither CABG nor PCI should be performed unless strictly necessary (i.e. STEMI, unstable angina) 22.1% 12.5% 22.2% 26.7% 
Only in selected cases (i.e. age criteria, left main disease) 40.7% 50.0% 44.4% 20.0% 
PCI should always be the default strategy and CABG should be considered only in unstable patients when PCI is not feasible 32.6% 25.0% 28.6% 53.3% 
     
During this pandemic AV surgery for non-COVID patients should be performed:          
Following standard recommendations 5.8% 12.5% 4.8% 6.7% 
Neither AV surgery nor TAVI should be performed unless strictly necessary (unstable or very symptomatic patients) 30.2% 25.0% 31.7% 26.7% 
Only in selected cases (i.e. age criteria, bicuspid valve) 51.2% 62.5% 54.0% 33.3% 
TAVI should always be the default strategy and AV surgery should be considered only in unstable patients when TAVI is not 
feasible 12.8% 0.0% 9.5% 33.3% 
 
UOB Confidential 
     
During this pandemic MV surgery for non-COVID patients should be performed:          
Following standard recommendations 3.5% 12.5% 3.2% 0.0% 
I don’t know 2.3% 0.0% 0.0% 13.3% 
MV surgery should never be performed unless strictly necessary (unstable or very symptomatic patients) 41.9% 37.5% 38.1% 60.0% 
Only in selected cases (i.e. age criteria, very symptomatic) 52.3% 50.0% 58.7% 26.7% 
     
After this pandemic, which of the following sentence will be true?         
Cardiac surgery activities will be significantly reduced in favour of interventional procedures (i.e. TAVI, PCI) 10.5% 12.5% 9.5% 13.3% 
Cardiac surgery activities will go back to normal 65.1% 62.5% 65.1% 66.7% 
I don’t know 24.4% 25.0% 25.4% 20.0% 
     
After this pandemic, future indications need be revised accouting for other factors (i.e. ICU beds utilization)          
I don’t know 8.1% 12.5% 7.9% 6.7% 
No 68.6% 75.0% 66.7% 73.3% 
Yes 23.3% 12.5% 25.4% 20.0% 
 
